Trevi Therapeutics
Clinical trials sponsored by Trevi Therapeutics, explained in plain language.
-
First human test for new IPF pill begins
Symptom relief Recruiting nowThis is an early safety study for a new extended-release tablet called NAL ER in people with Idiopathic Pulmonary Fibrosis (IPF). The main goal is to see if increasing doses are safe and well-tolerated, and to check for any effects on breathing. It will involve a small group of 1…
Phase: PHASE1 • Sponsor: Trevi Therapeutics • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Scientists test if a big meal changes how your body absorbs a pain drug
Knowledge-focused Recruiting nowThis early-stage study aims to understand if eating a high-fat, high-calorie meal changes how the body absorbs a long-acting version of the pain medication nalbuphine. It will involve 60 healthy volunteers who will take the drug once with food and once without, in a random order.…
Phase: PHASE1 • Sponsor: Trevi Therapeutics • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC